Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease.
about
Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@en
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@nl
type
label
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@en
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@nl
prefLabel
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@en
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@nl
P2860
P356
P1476
Chronic 5-Aminoimidazole-4-Car ...... Model of Huntington's Disease.
@en
P2093
Bernard J Jasmin
Marie-France Paré
P2860
P356
10.3389/FNEUR.2017.00516
P577
2017-09-27T00:00:00Z